Search

Your search keyword '"Leprosy metabolism"' showing total 291 results

Search Constraints

Start Over You searched for: Descriptor "Leprosy metabolism" Remove constraint Descriptor: "Leprosy metabolism"
291 results on '"Leprosy metabolism"'

Search Results

1. Cellular and molecular determinants of bacterial burden in leprosy granulomas revealed by single-cell multimodal omics.

3. The red flags of ulnar neuropathy in leprosy.

4. The role of Mannose-binding lectin in leprosy: A systematic review.

5. TLR-9 Plays a Role in Mycobacterium leprae -Induced Innate Immune Activation of A549 Alveolar Epithelial Cells.

6. Mycobacterium leprae induces a tolerogenic profile in monocyte-derived dendritic cells via TLR2 induction of IDO.

7. Mycobacterium leprae promotes triacylglycerol de novo synthesis through induction of GPAT3 expression in human premonocytic THP-1 cells.

8. Oct-6 transcriptional factor a possible biomarker for leprosy diagnosis.

9. The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.

10. Elevated IL-6R on CD4 + T cells promotes IL-6 driven Th17 cell responses in patients with T1R leprosy reactions.

11. High-density lipoprotein as a new target for leprosy therapy.

12. Association of IL-10 Gene Polymorphism With IL-10 Secretion by CD4 and T Regulatory Cells in Human Leprosy.

13. Analysis of HLA-G protein expression in leprosy.

14. Structure, stability and chaperone function of Mycobacterium leprae Heat Shock Protein 18 are differentially affected upon interaction with gold and silver nanoparticles.

15. Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae.

16. Notch Signaling Pathway Expression in the Skin of Leprosy Patients: Association With Skin and Neural Damage.

17. Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae.

18. Population Pharmacokinetic Model to Assess the Impact of Disease State on Thalidomide Pharmacokinetics.

19. Intracellular Mycobacterium leprae Utilizes Host Glucose as a Carbon Source in Schwann Cells.

20. Diet and nutrition: An important risk factor in leprosy.

21. Differential Expression of IFN- γ , IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum.

22. Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction.

24. Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease.

25. Lucio phenomenon mimicking antiphospholipid syndrome: The occurrence of antiphospholipid antibodies in a leprosy patient.

27. Meta-Analysis Identifies Major Histocompatiblity Complex Loci in or Near HLA-DRB1, HLA-DQA1, HLA-C as Associated with Leprosy in Chinese Han Population.

28. Myelination key factor krox-20 is downregulated in Schwann cells and murine sciatic nerves infected by Mycobacterium leprae.

29. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.

30. Endoplasmic Reticulum Stress Markers and Their Possible Implications in Leprosy's Pathogenesis.

31. Immunohistochemical characterization of the M4 macrophage population in leprosy skin lesions.

32. γδ T cells are associated with inflammation and immunopathogenesis of leprosy reactions.

33. PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves.

34. Nerve Growth Factor and Pathogenesis of Leprosy: Review and Update.

35. Mast cell heterogeneity and anti-inflammatory annexin A1 expression in leprosy skin lesions.

36. Type I Interferons, Autophagy and Host Metabolism in Leprosy.

37. Characterization of ML0314c of Mycobacterium leprae and deciphering its role in the immune response in leprosy patients.

38. A hypothetical role for Notch signaling pathway in immunopathogenesis of leprosy.

39. Aryl Hydrocarbon Receptor Controls Monocyte Differentiation into Dendritic Cells versus Macrophages.

40. Response of iNOS and its relationship with IL-22 and STAT3 in macrophage activity in the polar forms of leprosy.

41. Correlation between therapy and lipid profile of leprosy patients: is there a higher risk for developing cardiovascular diseases after treatment?

42. T helper cells in leprosy: An update.

43. Multifaceted role of lipids in Mycobacterium leprae.

44. Endothelium adhesion molecules ICAM-1, ICAM-2, VCAM-1 and VLA-4 expression in leprosy.

45. Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.

46. Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.

47. The involvement of endothelial mediators in leprosy.

48. [EXPERIMENTAL STUDY OF SPECIFIC ACTIVITY OF 1.3-DIAZINON-4 COM- POUND PYaTd1 DERIVATIVE IN VIVO].

49. Human NOD2 Recognizes Structurally Unique Muramyl Dipeptides from Mycobacterium leprae.

50. Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn's disease and leprosy.

Catalog

Books, media, physical & digital resources